Description

Product Description

Tislelizumab is a recombinant humanized monoclonal IgG4 antibody engineered to bind selectively to the PD-1 receptor on T cells. By blocking PD-1 interaction with its ligands PD-L1 and PD-L2, Tislelizumab modulates immune checkpoint pathways, enabling experimental investigation of immune activation, T-cell proliferation, and tumor microenvironment interactions.

Laboratory research utilizes Tislelizumab to explore mechanisms of immune checkpoint blockade, T-cell receptor signaling, cytokine release, and tumor-immune cell crosstalk. Its high specificity and affinity for PD-1 allow researchers to study T-cell modulation without off-target effects commonly seen with non-specific immune modulators.

Key experimental applications include:

• Immune checkpoint research: Studying PD-1/PD-L1 interactions and immune suppression in vitro and in vivo.

• T-cell activation studies: Examining T-cell proliferation, cytokine production, and cytotoxic responses.

• Tumor immunology models: Evaluating antibody effects on tumor-infiltrating lymphocytes and microenvironment modulation.

• Combination experiments: Investigating synergistic effects with other immunomodulatory agents, checkpoint inhibitors, or experimental therapies.

• Pharmacokinetic and pharmacodynamic studies: Assessing antibody distribution, receptor occupancy, and bioactivity in laboratory models.

Tislelizumab is supplied as a research-grade protein, typically as a sterile, lyophilized powder or solution with ≥99% purity (verified by SDS-PAGE, HPLC, and ELISA). It is suitable for in vitro assays, receptor binding studies, and preclinical animal models. The antibody’s stability and high affinity make it an ideal tool for mechanistic research in immuno-oncology and immune checkpoint studies.

Product Specifications

Mechanism of Action

Tislelizumab functions as a selective anti-PD-1 monoclonal antibody. Its mechanism of action in laboratory research involves binding to PD-1 receptors on T cells, thereby inhibiting interactions with PD-L1 and PD-L2 and modulating immune checkpoint signaling.

PD-1 Receptor Blockade

Tislelizumab binds with high affinity to PD-1, preventing ligand-mediated inhibitory signals. This blockade enhances T-cell activation, proliferation, and cytokine production in experimental models.

Immune Checkpoint Modulation

By inhibiting PD-1 signaling, Tislelizumab allows detailed study of T-cell-mediated immune responses, tumor immune evasion mechanisms, and immune microenvironment regulation.

Experimental Applications

• In vitro T-cell activation assays

• Cytotoxicity and cytokine release studies

• Tumor-infiltrating lymphocyte analyses in preclinical models

• Combination studies with other immunomodulatory agents

• Receptor occupancy and pharmacodynamic evaluations

Tislelizumab’s high specificity and humanized IgG4 backbone minimize off-target immune effects, making it suitable for mechanistic and translational research in immuno-oncology.

Side Effects

In laboratory studies, Tislelizumab shows minimal cytotoxicity at recommended experimental concentrations. Observed effects may include transient modulation of cytokine levels or T-cell proliferation in vitro or in vivo. It is not intended for clinical use outside controlled laboratory research.

Keywords

Tislelizumab, anti-PD-1 monoclonal antibody, immune checkpoint research, T-cell activation studies, immuno-oncology preclinical models, PD-1/PD-L1 pathway studies, laboratory research antibody, recombinant humanized antibody, high-purity mAb, factory antibody supplier, antibody wholesale China, biotech raw material manufacturer, low-price antibody supplier, China antibody manufacturer, OEM & bulk antibody production

Shipping Guarantee

All Tislelizumab shipments of Tislelizumab are handled using validated cold-chain logistics to maintain protein integrity and biological activity. Lyophilized powders or solutions are sealed in sterile, moisture-proof containers with secondary protective packaging and continuous temperature monitoring. Products are shipped via express international couriers with full tracking and insurance coverage, ensuring safe delivery and minimal degradation.

Trade Assurance

We guarantee the authenticity and high purity (≥99%) of Tislelizumab. Each batch undergoes stringent quality control, including SDS-PAGE, HPLC, ELISA, and functional binding assays to verify identity, purity, and biological activity. A Certificate of Analysis (CoA) is provided with each batch. Our trade assurance policy ensures replacement or refund for any deviation from listed specifications.

Payment Support

We Tislelizumab provide secure and flexible payment options for global research transactions, including PayPal, major credit cards (Visa, MasterCard, American Express), telegraphic transfer (T/T), and cryptocurrencies (USDT, Bitcoin, Ethereum). All transactions are encrypted and verified, ensuring confidentiality and fund security.

Disclaimer

All Tislelizumab products are intended for laboratory research use only. They are not drugs, medical devices, or diagnostics, and should not be administered to humans or animals. Researchers must adhere to institutional biosafety and chemical safety guidelines. Information provided is for scientific reference only and does not imply therapeutic efficacy, safety, or regulatory approval.